Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ALTERITY THERAPEUTICS LTD (PRAN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-16Jun-30-15Jun-30-14
   20-F20-F20-F
Revenues  4.86.37.8
            Revenue growth  -24.8%-19.5% 
Cost of goods sold  26.533.740.6
Gross profit  -21.7-27.4-32.7
            Gross margin  -457.1%-433.2%-417.1%
Selling, general and administrative   [+]3.64.54.9
Research and development  9.612.314.9
EBIT   [+]-8.5-10.5-12.4
            EBIT margin  -178.5%-166.6%-158.6%
Other income (expense), net  0.84.6-0.9
Pre-tax income  -7.7-5.9-13.3
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  0.00.00.0
            Net margin  0.0%0.0%0.0%
   
   
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy